Last reviewed · How we verify

NCT07151053

Duruöz Hand Index in Obstetric Brachial Plexus Palsy

Completed Last updated 2 September 2025
What this trial tests

trial in Obstetric Brachial Plexus Injury in 21 participants. Completed in 15 July 2022.

Timeline
5 March 2020
Primary endpoint
1 April 2022
15 July 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21
Start date5 March 2020
Primary completion1 April 2022
Estimated completion15 July 2022
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 6 to 18, any sex, with Obstetric Brachial Plexus Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstetric brachial plexus palsy (OBPP) arises from perinatal injury to the brachial plexus, resulting in varying degrees of motor and sensory impairment in the upper extremity. While existing assessment instruments primarily target unilateral limb function, they frequently overlook bimanual capabilities, which are essential for functional independence. This study aims to investigate the utility of the Duruöz Hand Index (DHI) as a reliable, valid, and practical instrument for evaluating functional limitations in individuals with OBPP. A cohort of 21 pediatric patients (aged 6-18 years) with OBPP was recruited from a tertiary university hospital in Turkey. Functional assessment included grip and pinch strength, range of motion, and upper extremity performance, measured using the Modified Mallet Classification, Brachial Plexus Outcome Measure (BPOM), Pediatric Outcomes Data Collection Instrument (PODCI), and DHI

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstetric Brachial Plexus Injury

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07151053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing